A detailed history of Northwestern Mutual Wealth Management CO transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 27,569 shares of AVXL stock, worth $234,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,569
Holding current value
$234,887
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$5.11 - $12.56 $140,877 - $346,266
27,569 New
27,569 $296,000
Q3 2023

Nov 14, 2023

BUY
$6.55 - $9.37 $8,744 - $12,508
1,335 New
1,335 $8,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $664M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.